3 Top Marijuana Stocks to Follow

Marijuana stocks started strong this month but collectively dropped again as of this writing. Nonetheless, investors are still willing to absorb losses for future gains. The potential earnings from this sector are simply too huge to be ignored. Cannabis companies are plugging in the loopholes to be on the road to profitability. Three marijuana stocks are worth watching in May:…

Read More

Why Aphria’s (TSX:APHA) Stock Price Is Tanking

So far, 2019 has been a great year for cannabis stocks, with record-breaking earnings and soaring stock prices across the board. Some top marijuana stocks are up as much as 89% ytd, while weed stocks as a class are up 33%. However, the benefits of this bull market are not being reaped equally. While top weed stocks are soaring, others…

Read More

3 Reasons Aphria Inc’s (TSX:APHA) Stock Has Been Tanking

It’s been almost six months since cannabis was legalized nationwide, and marijuana stocks are once again on the rise. One, however, is not rising with the tide. Over the past month, shares of Aphria Inc (TSX:APHA)(NYSE:APHA) have fallen 18.8%, with a particularly sharp sell-off having occurred in the past week. If you zoom out to a longer time horizon, the…

Read More

Why Is This Cannabis Stock Up 62%?

Despite having a share price of just $0.23 in 2015, OrganiGram Holdings Inc (TSXV:OGI) stock has quickly risen to a market cap of more than $1.3 billion. Since the start of 2019, shares are up another 62%. Now with a valuation that rivals other notable pot stocks like Green Organic Dutchman Holdings Ltd (TSX:TGOD) and Hexo Corp  (TSX:HEXO), why do shares seem…

Read More



Vancouver, BC, Feb. 25, 2019 (GLOBE NEWSWIRE) — INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”), has successfully completed testing on two batches  of oil and is working to finalize its application to Health Canada to allow for the sale of…

Read More

KALY – Kali-Extracts COPD Research Targeting $14 Billion Treatment Market To Be Featured In Online Corporate Update Next Week

Kali Extracts

DALLAS, Jan. 25, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced an online corporate update scheduled for Wednesday next week on January 30, 2019. The presentation will include updates on KALY’s developments with Puration, Inc, (USOTC: PURA) (“PURA”) and Generex Biotechnology, Inc. (OTCBB: GNBT). The presentation will also…

Read More